Abstracts

Near Elimination of HIV Transmission in a Demonstration Project of PrEP and ART

Background: Antiretroviral-based HIV prevention interventions, including pre-exposure prophylaxis (PrEP) and antiretroviral therapy (ART), showed high efficacy for HIV protection in clinical trials among African HIV serodiscordant couples. Assessing the effectiveness of these interventions, and their ability to complement one another, in implementation settings is a priority. Methods: We are conducting the Partners Demonstration Project, an…

Scale-Up of Preexposure Prophylaxis in San Francisco to Impact HIV Incidence

Background: Since 2007, rates of new HIV diagnoses in San Francisco (SF) decreased with widespread HIV testing, pooled HIV RNA testing for high-risk seronegatives, increased viral suppression rates, and grass-roots initiatives. Consumer demand for pre-exposure prophylaxis (PrEP) has increased since mid-2013. Local goals for PrEP scale-up have not been established. Methods: A simple model was…

FACTS 001 Phase III Trial of Pericoital Tenofovir 1% Gel for HIV Prevention in Women

Background: HIV prevention in women is a major public health priority. Pericoital vaginal application of tenofovir (TFV) gel has been demonstrated to prevent male-to-female HIV transmission in a proof of concept phase IIB trial. However, adherence to product is a critical driver of microbicide effectiveness. Additional data are required for licensure. Methods: FACTS 001 is…

Medical Male Circumcision of HIV-Infected Men Reduces Long-Term Penile HIV Shedding

Background: Medical male circumcision (MMC) for HIV prevention in uninfected men is increasing. In HIV-infected men, MMC is safe and reduces genital ulceration and HPV acquisition. MMC of HIV+ men reduced male-to-female transmission in observational studies, but in a randomized trial MMC was associated with increased HIV transmission to female partners if couples resumed intercourse…

PROMISE: Efficacy and Safety of 2 Strategies to Prevent Perinatal HIV Transmission

Background: There are limited clinical trial data comparing the efficacy and safety of antepartum (AP) antiretroviral (ARV) regimens for prevention of mother-to-child transmission (PMTCT) in women with high CD4 counts. Methods: PROMISE 1077BF/1077FF is an ongoing, prospective, open-label randomized trial being conducted in 14 sites in Africa and India among HIV+ pregnant and postpartum women…

Most Breastfeeding Women With High Viral Load Are Still Undiagnosed in Sub-Saharan Africa

Background: No study has assessed the proportion of HIV-positive pregnant or breastfeeding (PBF) women virally suppressed at population level. Furthermore, critical data assessing the cascade of care among PBF women are needed to inform program policy. We used data from three population surveys to assess these key indicators. Methods: Three household based surveys of individuals…